81% rise in Victoza sales drives Novo Nordisk earnings

Article Date: 27/04/2012 10:33
81% rise in Victoza sales drives Novo Nordisk earnings

Vacancy Search

Quick job search

Advanced Search

Latest News

Novartis bags EU nod for skin cancer combo, signs Amgen deal

Novartis bags EU nod for skin cancer combo, signs Amgen deal

Alexion rare disease therapies win EU approval

Alexion rare disease therapies win EU approval

Sanofi, Google team up to improve diabetes management

Sanofi, Google team up to improve diabetes management

AstraZeneca licenses brodalumab to Valeant

AstraZeneca licenses brodalumab to Valeant

Bayer puts finerenone into PIII in heart failure, kidney disease

Bayer puts finerenone into PIII in heart failure, kidney disease

ALK's house dust mite pill wins EU nod

ALK's house dust mite pill wins EU nod

Eisai and Purdue link to develop insomnia drug

Eisai and Purdue link to develop insomnia drug

B-MS buys right to acquire Promedior in $1.25bn deal

B-MS buys right to acquire Promedior in $1.25bn deal

Wales approves Celgene's Imnovid despite NICE 'no'

Wales approves Celgene's Imnovid despite NICE 'no'

Comms Team entry deadline approaching

Comms Team entry deadline approaching
more news